What If Ventures

Data updated June 29, 2026

Frisco, TX, United States

What If Ventures is a venture capital firm founded in 2020 and based in Frisco, Texas, United States. It invests from seed through pre-IPO and describes itself as focused on health, freedom, mental health, and disruptive healthcare, with some portfolio exposure to psychedelic and adjacent mental health companies.

In the psychedelic ecosystem, What If Ventures matters because its portfolio includes companies such as Atai Life Sciences, Beckley Psytech, and 2A Biosciences, all of which are publicly associated with psychedelic medicine or psychedelic-adjacent drug development. The firm’s public portfolio and team pages show continued interest in mental health innovation, addiction, biomarkers, and psychiatric drug development.

Investor Context

Venture Capital

Investment Context

This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.

Public Portfolio Examples

atai Life SciencesRecorded investment
Beckley PsytechRecorded investment

What If Ventures is a stage-flexible venture firm that backs stigmatized and under-capitalized healthcare categories, with public portfolio examples spanning mental health, addiction, biomarkers, personalized psychiatry, and psychedelic medicine. Its published portfolio includes psychedelic-relevant companies such as Atai Life Sciences, Beckley Psytech, and 2A Biosciences, making it a visible participant in the broader psychedelic ecosystem even though its thesis is wider than psychedelics alone.

Investor Type

Venture Capital Fund

Geographic Scope

Global

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement

Active

Investment Stage Focus

SeedSeries A/BGrowth / Late Stage

Investment Focus Areas

Drug Development